Medix (TSE:331A) Stock Based Compensation: 円0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:331A Medix Inc TSE:331A
20 GF Score
Price 円495.00
! 3 Warning Signs
View Full Analysis

What is Medix Stock Based Compensation?

Medix TSE:331A +0.41% 20 Stock Based Compensation is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:331A with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Medix's Stock Based Compensation for the three months ended in Mar. 2026 was 円0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.


Medix Stock Based Compensation Related Terms


Medix Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Medix's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medix Stock Based Compensation Chart

Medix Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
0.00 0.00 0.00 0.00

Medix Quarterly Data
Mar23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
TSE:331A
20GF Score
Medix Inc TSE:331A
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medix Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

What does a Stock Based Compensation of 円0 Mil mean?
Medix (TSE:331A) has a Stock Based Compensation of 円0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Medix and its competitors.
Is Medix's Stock Based Compensation too high?
Medix's current Stock Based Compensation is 円0 Mil. Overall, Medix has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Medix's Stock Based Compensation compare to APP and OMC?
Medix's Stock Based Compensation of 円0 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Media - Diversified company?
A good Stock Based Compensation depends on the Media - Diversified industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Medix and its competitors. Medix's current Stock Based Compensation is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medix stock overvalued right now?
Medix (TSE:331A) has a current Stock Based Compensation of 円0 Mil. The current Stock Based Compensation is 円0 Mil. Medix's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Medix (TSE:331A), the current Stock Based Compensation is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medix Business Description

Address 1-105 Kanda-Jinbo-cho, 19th Floor, Jimbocho Mitsui Building, Chiyoda-ku, Tokyo, JPN, 101-0051
Medix Inc is an internet advertising agency that places the utmost importance on understanding its clients' business models deeply and helping them solve problems over the medium to long term. It is engaged in Digital marketing services including creative design and production, data parsing and analysis, and Internet advertising services. The company provides services in the digital marketing field to clients in various lines and industries.
20GF Score

Get the complete analysis for TSE:331A

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円495.00
Price